Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply

Схожі ресурси

• Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
  за авторством: Florakis, D, та інші
  Опубліковано: (2000)
• Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
  за авторством: Drake, WM, та інші
  Опубліковано: (1998)
• Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
  за авторством: Frajese, G, та інші
  Опубліковано: (2001)
• Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
  за авторством: le Roux, C, та інші
  Опубліковано: (2002)
• Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
  за авторством: Chung, T, та інші
  Опубліковано: (2008)